Last reviewed · How we verify
NCT03846557: PRECISA
PRospective Evaluation Complementing Investigation With Acurate Neo Device
trial testing Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis in 300 participants. Completed in 2 October 2021.
2 September 2021
Quick facts
| Lead sponsor | Fundación EPIC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 20 May 2019 |
| Primary completion | 2 September 2021 |
| Estimated completion | 2 October 2021 |
| Sites | 10 locations across Spain |
Drugs / interventions tested
- Transcatheter Aortic Valve Implantation (TAVI)
Conditions studied
- Aortic Stenosis — all drugs for Aortic Stenosis →
Sponsor
Fundación EPIC — full company profile →
Who can join
18 and older, any sex, with Aortic Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study collects real-world data of patients who were treated with the Acurate Neo TAVI System and evaluates early and midterm clinical outcomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Experience with the ACURATE neo and neo2 transcatheter aortic valves in Spain. The PRECISA (PRospective Evaluation Complementing Investigation with ACURATE devices) registry.
Tébar D, Carrillo X, García Del Blanco B, Gómez-Hospital JA, et al · · 2024 · cited 1× · PMID 38577931 · DOI 10.1002/ccd.31032
Verify or expand the search:
- PubMed search for NCT03846557
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcatheter Aortic Valve Implantation (TAVI)
Trials testing the same drug.
- NCT07179302 — Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy · completed
- NCT05672823 — Upper Extremity Versus Lower Extremity Accessory Access Sites During Transcatheter Aortic Valve Implantation · NA · completed
- NCT05464472 — Impact of Transcatheter Aortic Valve Implantation (TAVI) on Cognitive Functions · unknown
- NCT04860752 — SAPIEN 3 Ultra EU PMS · completed
- NCT04517955 — TAVI in Intermediate Risk Septuagenarians With Risk Factors Not Captured by the Traditional Surgical Risk Scores · unknown
Other recruiting trials for Aortic Stenosis
Currently open trials in the same condition.
- NCT07197736 — DELINEATE-Prospective · recruiting
- NCT07230964 — Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacemen · NA · recruiting
- NCT07205068 — Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and P · NA · recruiting
- NCT07052071 — Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis · recruiting
- NCT07144189 — AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography · recruiting
Other Fundación EPIC trials
Trials by the same sponsor.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07260474 — Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage Closure · NA · not yet recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
- NCT07190690 — Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both · NA · recruiting
- NCT07256249 — Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selutio · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03846557 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación EPIC
- Last refreshed: 18 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03846557.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing